Patents/Assignees

Celgene Corporation

68 patents in portfolio

US11883389utility2024
Formulations of 2-(4-chlorophenyl)-n-((2-(2,6- Dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0 cites
US11873283utility2024
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione Compounds, Compositions Thereof, and Methods of Treatment Therewith
0 cites
US11866417utility2024
Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione Hemihydrate, Compositions and Methods of Use Thereof
0 cites
US11834675utility2023
T Lymphocyte Production Methods and T Lymphocytes Produced Thereby
0 cites
US11806365utility2023
Modified T Lymphocytes Comprising a CD52 Antibody-inducible Caspase and Methods of Apoptosis
0 cites
US11787860utility2023
Anti-cd47 Antibodies and Uses Thereof
0 cites
US11780801utility2023
Methods of Synthesis of (1r,2r,5r)-5-amino-2-methyl-cyclohexanol Hydrochloride and Intermediates Useful Therein
0 cites
US11779580utility2023
Pharmaceutical Compositions Comprising (s)-4-(4-(4- (((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrtle and Methods of Using The
0 cites
USRE049647reissue2023
Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
0 cites
US11739075utility2023
Cereblon Binding Compounds, Compositions Thereof, and Methods of Treatment Therewith
0 cites
US11733233utility2023
Compositions and Methods for Inducing Conformational Changes in Cereblon and Other E3 Ubiquitin Ligases
0 cites
US11726080utility2023
Methods for Treating Multiple Myeloma and the Use of Companion Biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile
0 cites
US11701362utility2023
Compositions and Methods of Use of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h-purin-9-yl]-1- Methylcyclohexane-1-carboxamide
0 cites
US11666579utility2023
Methods of Treating Hematological Malignancies Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
0 cites
US11660302utility2023
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the Treatment of Systemic Lupus Erythematosus
0 cites
US11660297utility2023
Antiproliferative Compounds and Second Active Agents for Combined Use
0 cites
US11655232utility2023
Polymorphic Forms of 3-(4-amino-1-oxo-1,3 Dihydro-isoindol-2-yl)-piperidine-2,6-dione
0 cites
US11644461utility2023
Methods for Measuring Small Molecule Affinity to Cereblon
0 cites
US11634407utility2023
Cereblon Binding Compounds, Compositions Thereof, and Methods of Treatment Therewith
0 cites
US11628172utility2023
Methods of Treating Chronic Lymphocytic Leukemia Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
0 cites

← PreviousPage 3 of 4Next →